Jeff Bezos Backs “Drug Smuggler” to Fight Alzheimer’s (ad) A small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer’s, Parkinson’s and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>> Click here to learn more

•   Apple Inc. (AAPL)

  

  • (12/19) Apple Needs to Sell its Vision (wsj.com)
  • (12/19) With a $3 Trillion Market Cap, Is Apple Stock a Sell? (msn.com)
  • (12/19) Here’s Why I Just Sold These 2 Blue-Chip Stocks, Even Though They’re Great Businesses(fool.com)
  • (12/19) Stock Splits Elusive Even After Scorching Chip Rally (finance.yahoo.com)
  • (12/19) Doug Kass: My 10 Surprises List for 2024 (finance.yahoo.com)
  • (12/19) Apple may be a 4T company by next year, but is it a buy now? (marketbeat.com)
  • (12/19) 2 former tech trailblazers rising like a phoenix (AAPL) (marketbeat.com)
  • (12/19) Beeper Mini Vs. Apple’s iMessage Battle Goes Mainstream: Bipartisan Group Of Senators Urge DOJ To Launch Antitrust Investigation (benzinga.com)
  • (12/19) Steal Deal: Apple’s M2 13-inch MacBook Air Is Now Available At $899, Just In Time For Holidays (benzinga.com)
  • (12/19) Apple iPad Pro May Support Magsafe Charging In 2024: Report (benzinga.com)
•   Amazon.com, Inc. (AMZN)

  

  • (12/19) Amazon.com (NASDAQ:AMZN) Reaches New 12-Month High Following Analyst Upgrade(marketbeat.com)
  • (12/19) Bull of the Day: Amazon.com, Inc. (AMZN) (msn.com)
  • (12/19) 2 Reasons to Buy Amazon Stock Like There’s No Tomorrow (fool.com)
  • (12/19) BEVs are out, hybrids are in; here’s where to invest (AMZN) (marketbeat.com)
  • (12/19) Amazon.com, Inc. (NASDAQ:AMZN) Holdings Lifted by Procyon Advisors LLC(marketbeat.com)
  • (12/19) TikTok Allegedly Favored Amazon Accounts, Internal Communications Reveal (msn.com)
  • (12/18) Amazon is reportedly in talks to invest in a bankrupt company (invezz.com)
  • (12/18) Amazon To The Rescue? Potential Diamond Sports Deal May Bring 30 MLB, NBA, NHL Teams To Prime Video (msn.com)
  • (12/18) Amazon to vacate another downtown Seattle tower (bizjournals.com)
  • (12/18) He’s leading Amazon Kuiper’s expansion in Kirkland as first satellites come online(bizjournals.com)
•   Alphabet Inc. (GOOGL)

  

  • (12/19) Alphabet to pay $700 million to US consumers over Google Play feud, will also alter policies(cnbctv18.com)
  • (12/19) Alphabet to pay $700m to end Google app store row (irishtimes.com)
  • (12/19) Google to pay $700 million to settle Play Store lawsuit (msn.com)
  • (12/19) Google to pay $700 mln to US consumers, states in Play store settlement (reuters.com)
  • (12/19) Google Reaches Play Store Settlement. There’s Something Bigger at Stake for Alphabet and Apple. (msn.com)
  • (12/19) Google Agrees To $700M Settlement In Antitrust Case, Promises Play Store Policy Revisions(benzinga.com)
  • (12/19) Procyon Advisors LLC Raises Stake in Alphabet Inc. (NASDAQ:GOOGL) (marketbeat.com)
  • (12/19) Google to pay US$700m to US consumers, states in Play store settlement (malaymail.com)
  • (12/19) Alphabet reaches $700 mn deal in Google Play feud, to alter policies (business-standard.com)
  • (12/18) Why Alphabet, Amazon, and Other “Magnificent Seven” Stocks Rallied Today (msn.com)
•   Meta Platforms, Inc. (META)

  

  • CEO Mark Zuckerberg sold 28,009 shares of Meta Platforms stock in a transaction on Friday, December 15th. The stock was sold at an average price of $335.91, for a total value of $9,408,503.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
  • (12/19) Meta’s decisions to remove 2 videos of Israel-Hamas war reversed by Oversight Board(msn.com)
  • (12/19) Meta automated tools ‘mistakenly’ removed valuable content about Israel-Gaza conflict, Oversight Board says (news.yahoo.com)
  • (12/19) Oversight Board reverses Meta’s initial decisions to remove 2 videos of Israel-Hamas war(msn.com)
  • (12/19) The Zacks Analyst Blog Highlights Meta Platforms, Intel, NVIDIA, UiPath and Microsoft(finance.yahoo.com)
  • (12/19) Meta removed two Israel-Hamas videos unnecessarily, Oversight Board says (msn.com)
  • (12/19) Meta faces accusations over content moderation in Israel-Hamas conflict(finance.yahoo.com)
  • (12/19) Meta Oversight Board says Israel-Hamas videos should not have been removed(finance.yahoo.com)
  • (12/19) Meta Platforms, Inc. (NASDAQ:META) Shares Sold by Vontobel Holding Ltd.(marketbeat.com)
  • (12/18) Dogecoin Designer Asks Why No Action Against Meta Despite Child Sexual Abuse Allegations, Elon Musk Responds… (msn.com)
  • (12/18) NC schools sue social media companies for exploiting ‘addictive nature’ of platforms(news.yahoo.com)
•   Microsoft Co. (MSFT)

  

  • (12/19) Mapping company TomTom teams up with Microsoft to bring AI assistant for vehicles(msn.com)
  • (12/19) Elevat Announces Groundbreaking Technical Partnership with Microsoft to Revolutionize IoT with the Heavy Machinery industries (finance.yahoo.com)
  • (12/19) 2 former tech trailblazers rising like a phoenix (MSFT) (marketbeat.com)
  • (12/19) Daymark Wealth Partners LLC Purchases 139,841 Shares of Microsoft Co. (NASDAQ:MSFT)(marketbeat.com)
  • (12/19) TomTom creates AI-based conversational assistant for vehicles with Microsoft(finance.yahoo.com)
  • (12/18) You Can’t Spell Mania without AI: 4-Stock Play Yields 7.4% (marketbeat.com)
  • (12/18) Microsoft (MSFT) Laps the Stock Market: Here’s Why (finance.yahoo.com)
  • (12/18) Navigating Market Uncertainty: Intrinsic Value of Microsoft Corp (finance.yahoo.com)
  • (12/18) Microsoft Co. (NASDAQ:MSFT) Shares Bought by HS Management Partners LLC(marketbeat.com)

• ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $40.00 price target on the stock, up previously from $31.00. This represents a 34.4% upside from the current price of $29.77.
• American International Group (NYSE:AIG) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $83.00 price target on the stock, up previously from $72.00. This represents a 23.1% upside from the current price of $67.44.
• Amgen (NASDAQ:AMGN) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $326.00 price target on the stock, up previously from $286.00. This represents a 16.4% upside from the current price of $280.08.
• Arvinas (NASDAQ:ARVN) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $63.00 price target on the stock, up previously from $25.00. This represents a 72.1% upside from the current price of $36.60.
• Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $20.00 price target on the stock, up previously from $15.00. This represents a 51.4% upside from the current price of $13.21.
• Itron (NASDAQ:ITRI) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $91.00 price target on the stock, up previously from $72.00. This represents a 23.7% upside from the current price of $73.55.
• Invivyd (NASDAQ:IVVD) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $4.00 price target on the stock, up previously from $1.00. This represents a 30.3% upside from the current price of $3.07.
• Sunnova Energy International (NYSE:NOVA) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $26.00 price target on the stock, up previously from $13.00. This represents a 75.8% upside from the current price of $14.79.
• Rockwell Automation (NYSE:ROK) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $357.00 price target on the stock, up previously from $280.00. This represents a 15.0% upside from the current price of $310.38.
• Sunrun (NASDAQ:RUN) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $31.00 price target on the stock, up previously from $15.00. This represents a 62.7% upside from the current price of $19.05.
• Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $55.00 price target on the stock, up previously from $29.00. This represents a 19.3% upside from the current price of $46.12.
• Wave Life Sciences (NASDAQ:WVE) was upgraded by analysts at SVB Leerink LLC from a “market perform” rating to an “outperform” rating. They now have a $12.00 price target on the stock, up previously from $5.00. This represents a 138.1% upside from the current price of $5.04.
• View today’s most recent analysts’ upgrades at MarketBeat.com

Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (ad) Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. Analyze Any Stock Free

• Array Technologies (NASDAQ:ARRY) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $22.00 price target on the stock, down previously from $26.00. This represents a 21.0% upside from the current price of $18.18.
• Banco de Chile (NYSE:BCH) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.The current price is $23.04.
• Banco Santander-Chile (NYSE:BSAC) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.The current price is $19.65.
• Masonite International (NYSE:DOOR) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating. They now have a $92.00 price target on the stock, down previously from $106.00. This represents a 2.9% upside from the current price of $89.45.
• Equinor ASA (NYSE:EQNR) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating.The current price is $31.51.
• Disc Medicine (NASDAQ:IRON) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $65.00 price target on the stock, up previously from $56.00. This represents a 12.0% upside from the current price of $58.05.
• Kymera Therapeutics (NASDAQ:KYMR) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $26.00 price target on the stock. This represents a 3.6% upside from the current price of $25.09.
• PureCycle Technologies (NYSE:PCT) was downgraded by analysts at Roth Mkm from a “buy” rating to a “neutral” rating. They now have a $3.00 price target on the stock, down previously from $6.00. This represents a 7.1% downside from the current price of $3.23.
• PepsiCo (NASDAQ:PEP) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $176.00 price target on the stock, down previously from $185.00. This represents a 4.6% upside from the current price of $168.28.
• Piper Sandler Companies (NYSE:PIPR) was downgraded by analysts at Northland Securities from an “outperform” rating to a “market perform” rating.The current price is $175.89.
• Plug Power (NASDAQ:PLUG) was downgraded by analysts at Piper Sandler from a “neutral” rating to an “underweight” rating. They now have a $2.30 price target on the stock, down previously from $6.50. This represents a 48.2% downside from the current price of $4.44.
• Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $4.00 price target on the stock, down previously from $10.00. This represents a 3.8% downside from the current price of $4.16.
• PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $28.00 price target on the stock. This represents a 0.4% upside from the current price of $27.90.
• uniQure (NASDAQ:QURE) was downgraded by analysts at Mizuho from a “buy” rating to a “neutral” rating. They now have a $10.00 price target on the stock, down previously from $52.00. This represents a 47.9% upside from the current price of $6.76.
• ScanSource (NASDAQ:SCSC) was downgraded by analysts at Northcoast Research from a “buy” rating to a “neutral” rating. They now have a $36.00 price target on the stock. This represents a 7.0% downside from the current price of $38.71.
• SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $105.00 price target on the stock, down previously from $110.00. This represents a 6.4% upside from the current price of $98.64.
• SiteOne Landscape Supply (NYSE:SITE) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $167.00 price target on the stock, up previously from $150.00. This represents a 2.0% upside from the current price of $163.77.
• Vigil Neuroscience (NASDAQ:VIGL) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $4.00 price target on the stock, down previously from $13.00. This represents a 11.1% upside from the current price of $3.60.
• Vertex Energy (NASDAQ:VTNR) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $4.00 price target on the stock, down previously from $6.00. This represents a 14.9% upside from the current price of $3.48.
• Zurn Elkay Water Solutions (NYSE:ZWS) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $31.00 price target on the stock. This represents a 4.8% upside from the current price of $29.59.
• View today’s most recent analysts’ downgrades at MarketBeat.com

• Arcellx (NASDAQ:ACLX) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $66.00 price target on the stock. This represents a 26.4% upside from the current price of $52.21.
• BARK (NYSE:BARK) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $1.34 price target on the stock. This represents a 80.2% upside from the current price of $0.74.
• Bruker (NASDAQ:BRKR) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $72.00 price target on the stock. This represents a 2.5% downside from the current price of $73.85.
• Chewy (NYSE:CHWY) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $27.00 price target on the stock. This represents a 16.7% upside from the current price of $23.14.
• Comstock Resources (NYSE:CRK) is now covered by analysts at Siebert Williams Shank. They set a “hold” rating and a $10.00 price target on the stock. This represents a 13.8% upside from the current price of $8.79.
• Equifax (NYSE:EFX) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $273.00 price target on the stock. This represents a 9.3% upside from the current price of $249.71.
• Elanco Animal Health (NYSE:ELAN) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $17.00 price target on the stock. This represents a 20.4% upside from the current price of $14.12.
• Exelixis (NASDAQ:EXEL) is now covered by analysts at BTIG Research. They set a “buy” rating and a $27.00 price target on the stock. This represents a 14.0% upside from the current price of $23.69.
• Freshpet (NASDAQ:FRPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $80.00 price target on the stock. This represents a 5.8% downside from the current price of $84.95.
• Gulfport Energy (NASDAQ:GPOR) is now covered by analysts at Siebert Williams Shank. They set a “buy” rating and a $200.00 price target on the stock. This represents a 51.6% upside from the current price of $131.96.
• Hillenbrand (NYSE:HI) is now covered by analysts at CL King. They set a “strong-buy” rating and a $61.00 price target on the stock. This represents a 33.8% upside from the current price of $45.58.
• Immunome (NASDAQ:IMNM) is now covered by analysts at Wedbush. They set an “outperform” rating and a $12.00 price target on the stock. This represents a 49.4% upside from the current price of $8.03.
• Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Scotiabank. They set a “sector perform” rating on the stock.The current price is $62.50.
• MoneyLion (NYSE:ML) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $75.00 price target on the stock. This represents a 39.2% upside from the current price of $53.87.
• Myriad Genetics (NASDAQ:MYGN) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $20.00 price target on the stock. This represents a 4.6% downside from the current price of $20.96.
• New Fortress Energy (NASDAQ:NFE) is now covered by analysts at Capital One Financial Co.. They set an “equal weight” rating on the stock.The current price is $36.92.
• Nextracker (NASDAQ:NXT) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $60.00 price target on the stock. This represents a 30.7% upside from the current price of $45.92.
• PetIQ (NASDAQ:PETQ) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $22.00 price target on the stock. This represents a 17.0% upside from the current price of $18.80.
• Pool (NASDAQ:POOL) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $400.00 price target on the stock. This represents a 1.8% upside from the current price of $392.79.
• Patterson-UTI Energy (NASDAQ:PTEN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $12.00 price target on the stock. This represents a 6.7% upside from the current price of $11.25.
• Qiagen (NYSE:QGEN) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $44.00 price target on the stock. This represents a 3.1% upside from the current price of $42.67.
• REE Automotive (NASDAQ:REE) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $15.00 price target on the stock. This represents a 197.0% upside from the current price of $5.05.
• Revvity (NYSE:RVTY) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $95.00 price target on the stock. This represents a 8.9% downside from the current price of $104.29.
• Synovus Financial (NYSE:SNV) is now covered by analysts at Stephens. They set an “equal weight” rating and a $40.00 price target on the stock. This represents a 3.1% upside from the current price of $38.79.
• SouthState (NASDAQ:SSB) is now covered by analysts at Stephens. They set an “equal weight” rating and a $78.00 price target on the stock. This represents a 10.6% downside from the current price of $87.24.
• TransUnion (NYSE:TRU) is now covered by analysts at Oppenheimer Holdings Inc.. They set an “outperform” rating and a $81.00 price target on the stock. This represents a 16.3% upside from the current price of $69.63.
• Petco Health and Wellness (NASDAQ:WOOF) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $3.11 price target on the stock. This represents a 5.1% upside from the current price of $2.96.
• Yum China (NYSE:YUMC) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $58.00 price target on the stock. This represents a 41.7% upside from the current price of $40.94.
• View today’s most recent analysts’ new coverage at MarketBeat.com

Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:

Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.

If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.

© 2006-2023 American Consumer News, LLC dba MarketBeat.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.

Today’s Bonus Content: The A.I. Trend Has These 7 Stocks Set To Soar